CLINICAL_TRIALS
trial_result
· 2015-07-23
Clinical Trial Update: Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant Patients [Phase 2]
Summary
A Phase 2 study evaluated the pharmacokinetics of LCP-Tacro in stable kidney transplant recipients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Veloxis Pharmaceuticals | Conditions: Renal Failure | Phase 2 | Status: COMPLETED | Results posted: 2015-07-23